Positron appoints new medical director

TriMed Staff | | Health Imaging | Artificial Intelligence
Positron’s board of directors has appointed Michael E. Merhige, MD, as their medical director.

Merhige will be responsible for providing clinical leadership and has designated his practice as a signature show site for Positron software developers and customers, according to the Houston-based company. He is currently director of the Heart Center of Niagara in Niagara Falls, N.Y., which specializes in the noninvasive management of coronary disease guided by PET myocardial perfusion imaging. 

TriMed Staff

Related Content

Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Routine abdominal CTs offer insight into cardiovascular risk
Up to half of medical organizations either already using or preparing to implement AI

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.